AU2010264200B2 - Method for isolating cimiracemate A - Google Patents

Method for isolating cimiracemate A Download PDF

Info

Publication number
AU2010264200B2
AU2010264200B2 AU2010264200A AU2010264200A AU2010264200B2 AU 2010264200 B2 AU2010264200 B2 AU 2010264200B2 AU 2010264200 A AU2010264200 A AU 2010264200A AU 2010264200 A AU2010264200 A AU 2010264200A AU 2010264200 B2 AU2010264200 B2 AU 2010264200B2
Authority
AU
Australia
Prior art keywords
cimiracemate
extraction
water
cimicifuga
species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2010264200A
Other languages
English (en)
Other versions
AU2010264200A1 (en
Inventor
Allan Sy Lau
Lai Hung Cindy Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Versitech Ltd
Bagi Research Ltd
Original Assignee
Versitech Ltd
Bagi Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Versitech Ltd, Bagi Research Ltd filed Critical Versitech Ltd
Publication of AU2010264200A1 publication Critical patent/AU2010264200A1/en
Assigned to PURAPHARM COMPANY LIMITED, VERSITECH LIMITED reassignment PURAPHARM COMPANY LIMITED Request for Assignment Assignors: PURAPHARM INTERNATIONAL (HK) LIMITED, VERSITECH LIMITED
Assigned to BAGI RESEARCH LIMITED, VERSITECH LIMITED reassignment BAGI RESEARCH LIMITED Amend patent request/document other than specification (104) Assignors: PURAPHARM COMPANY LIMITED, VERSITECH LIMITED
Application granted granted Critical
Publication of AU2010264200B2 publication Critical patent/AU2010264200B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Compounds Of Unknown Constitution (AREA)
AU2010264200A 2009-06-21 2010-06-21 Method for isolating cimiracemate A Active AU2010264200B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21896209P 2009-06-21 2009-06-21
US61/218,962 2009-06-21
PCT/IB2010/001772 WO2010150102A2 (en) 2009-06-21 2010-06-21 Efficient isolation of cimiracemate a, and methods of use

Publications (2)

Publication Number Publication Date
AU2010264200A1 AU2010264200A1 (en) 2012-01-19
AU2010264200B2 true AU2010264200B2 (en) 2015-04-30

Family

ID=43386961

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010264200A Active AU2010264200B2 (en) 2009-06-21 2010-06-21 Method for isolating cimiracemate A

Country Status (9)

Country Link
US (1) US8633332B2 (enExample)
EP (1) EP2445859B8 (enExample)
JP (1) JP5773997B2 (enExample)
CN (1) CN102625791B (enExample)
AU (1) AU2010264200B2 (enExample)
CA (1) CA2766002C (enExample)
DK (1) DK2445859T3 (enExample)
ES (1) ES2524341T3 (enExample)
WO (1) WO2010150102A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010079406A1 (en) * 2009-01-12 2010-07-15 Purapharm International (Hk) Limited Compounds and uses thereof for treating inflammation and modulating immune responses
CN105954381A (zh) * 2016-04-22 2016-09-21 广西壮族自治区梧州食品药品检验所 一种升麻中异阿魏酸的测定方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5420569B2 (enExample) * 1974-02-08 1979-07-24
JP5139629B2 (ja) * 2005-06-28 2013-02-06 江崎グリコ株式会社 ＴＮＦ−αおよび一酸化窒素産生抑制剤
JP2007238509A (ja) * 2006-03-09 2007-09-20 Asahi Breweries Ltd 肌症状改善剤、それを含む肌症状改善用のサプリメント、食品、飲料及び医薬
JP2007238559A (ja) * 2006-03-10 2007-09-20 Nagoya City Univ 未成熟樹状細胞活性化剤及びその使用
KR100830553B1 (ko) * 2006-12-08 2008-05-21 Sk케미칼 주식회사 독활 및 승마 혼합생약추출물을 포함하는 염증관련 질환예방 및 치료용 조성물
WO2010079406A1 (en) * 2009-01-12 2010-07-15 Purapharm International (Hk) Limited Compounds and uses thereof for treating inflammation and modulating immune responses

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BURDETTE, J.E. et al., Journal of Agricultural and Food Chemistry, 2002, vol. 50, pages 7022-7028. *
CHEN, S-N. et al., Phytochemistry, 2002, vol. 61, pages 409-413. *
HE, K. et al, Journal of Chromatography A, 2006, vol. 1112, pages 241-254 *

Also Published As

Publication number Publication date
DK2445859T3 (en) 2015-01-05
JP2012530691A (ja) 2012-12-06
US20120190882A1 (en) 2012-07-26
WO2010150102A3 (en) 2011-03-24
EP2445859A2 (en) 2012-05-02
CA2766002A1 (en) 2010-12-29
HK1169380A1 (en) 2013-01-25
CN102625791A (zh) 2012-08-01
US8633332B2 (en) 2014-01-21
JP5773997B2 (ja) 2015-09-02
EP2445859B8 (en) 2015-04-22
CN102625791B (zh) 2014-12-24
WO2010150102A2 (en) 2010-12-29
EP2445859A4 (en) 2013-03-13
ES2524341T3 (es) 2014-12-05
AU2010264200A1 (en) 2012-01-19
EP2445859B1 (en) 2014-09-24
CA2766002C (en) 2017-02-28

Similar Documents

Publication Publication Date Title
CN1271083C (zh) 从竹子中提取的三萜总皂甙元的组成、方法及其用途
JP6059756B2 (ja) 新規ボスウェリア低極性ゴム樹脂抽出物およびその相乗的組成物
JP2013508352A (ja) アセトゲニンを含む抽出物、フラクションおよび組成物ならびにそれらの応用
JP2002501030A5 (enExample)
US10772932B2 (en) Medicament for use in treating cardiovascular and cerebrovascular diseases
JP2016532724A (ja) エンブリカのオフィシナリスの種子の抽出物の医療用組成物およびその調製方法
CN102772487A (zh) 一种丹参软胶囊的制备方法
AU2010264200B2 (en) Method for isolating cimiracemate A
CN102905529B (zh) 含有非酸性乳香油分馏物的组合物作为用于提高生物制剂的生物利用度的生物增强剂
CN103142916B (zh) 一种预防和治疗老年性痴呆病的药物
RU2399379C2 (ru) Экстракт salix, его использование и композиции, его содержащие
CN101703561A (zh) 一种治疗骨质疏松症的杜仲有效部位及其制备方法
KR102430968B1 (ko) 골질환의 예방 또는 치료용 식물 추출물 조성물
HK1169380B (en) Method for isolating cimiracemate a
Yang et al. OF USE
WO2023217115A1 (zh) 红肉苹果和樱桃李组合物及其在抗动脉粥样硬化方面的应用
US10736862B2 (en) Method for producing extracts containing hydroxycinnamic compounds from vegetable waste products
KR100631432B1 (ko) 신경세포 보호활성을 갖는 아세틸시코닌을 포함하는퇴행성 뇌질환 예방 및 치료용 약학 조성물
JPH0398562A (ja) 飲料組成物
Vishal et al. A REVIEW ON NIGELLA SATIVA SEEDS-A MARVEL HERB
CN105754710A (zh) 一种茶油的制备方法及茶油制品
CN105998358A (zh) 一种具有抗氧化活性与α-葡萄糖苷酶抑制活性的枸杞叶多酚制备方法
KR20220105462A (ko) 모과 및 홍화씨 추출물을 포함하는 염증 질환 예방 또는 치료용 약학적 조성물
CN120678876A (zh) 一种缓解炎性衰老的中药有效部位组合物、中药制剂和应用
CN115043804A (zh) 一种从傣药中提取的倍半萜类化合物、含化合物的傣药组合物及其制备方法和用途

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: PURAPHARM COMPANY LIMITED; VERSITECH LIMITED

Free format text: FORMER APPLICANT(S): VERSITECH LIMITED; PURAPHARM INTERNATIONAL (HK) LIMITED

FGA Letters patent sealed or granted (standard patent)